U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681882) titled 'First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors' on June 26.
Brief Summary: This clinical trial is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy signals of DS1025a, given as a single agent to participants with advanced, metastatic, or unresectable solid tumors.
Study Start Date: Aug. 03
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Metastatic Solid Tumor
Unresectable Solid Tumor
Intervention:
DRUG: DS1025a
Administered on Day 1
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daiichi Sankyo
Disclaimer: Curated by HT ...